{
  "cik": "0001390478",
  "name": "SELLAS Life Sciences Group, Inc.",
  "entityType": "operating",
  "sic": "2834",
  "sicDescription": "Pharmaceutical Preparations",
  "stateOfIncorporation": "DE",
  "stateOfIncorporationDescription": "DE",
  "fiscalYearEnd": "1231",
  "tickers": [
    "SLS"
  ],
  "exchanges": [
    "Nasdaq"
  ],
  "ein": "000000000",
  "description": "",
  "website": "",
  "investorWebsite": "",
  "category": "Non-accelerated filer<br>Smaller reporting company",
  "phone": "6462005278",
  "flags": "",
  "formerNames": [
    {
      "name": "GALENA BIOPHARMA, INC.",
      "from": "2011-09-26T04:00:00.000Z",
      "to": "2017-12-15T05:00:00.000Z"
    },
    {
      "name": "Galena Biopharma, Inc.",
      "from": "2011-09-26T04:00:00.000Z",
      "to": "2017-12-15T05:00:00.000Z"
    },
    {
      "name": "RXI PHARMACEUTICALS CORP",
      "from": "2007-02-07T05:00:00.000Z",
      "to": "2011-09-21T04:00:00.000Z"
    }
  ],
  "filings_count": 1000,
  "download_timestamp": "2025-08-02 07:12:03 UTC"
}